Use of palivizumab and infection control measures to control an outbreak of respiratory syncytial virus in a neonatal intensive care unit confirmed by real-time polymerase chain reaction.
AffiliationDepartment of Clinical Microbiology, University College Hospital, Galway, Ireland. firstname.lastname@example.org
Intensive Care, Neonatal
Polymerase Chain Reaction
Respiratory Syncytial Virus Infections
Respiratory Syncytial Virus, Human
MetadataShow full item record
CitationUse of palivizumab and infection control measures to control an outbreak of respiratory syncytial virus in a neonatal intensive care unit confirmed by real-time polymerase chain reaction. 2011, 77 (4):338-42 J. Hosp. Infect.
JournalThe Journal of hospital infection
AbstractRespiratory syncytial virus (RSV) is a potentially life-threatening infection in premature infants. We report an outbreak involving four infants in the neonatal intensive care unit (NICU) of our hospital that occurred in February 2010. RSV A infection was confirmed by real-time polymerase chain reaction. Palivizumab was administered to all infants in the NICU. There were no additional symptomatic cases and repeat RSV surveillance confirmed that there was no further cross-transmission within the unit. The outbreak highlighted the infection control challenge of very high bed occupancy in the unit and the usefulness of molecular methods in facilitating detection and management.
- Use of palivizumab to control an outbreak of syncytial respiratory virus in a neonatal intensive care unit.
- Authors: Abadesso C, Almeida HI, Virella D, Carreiro MH, Machado MC
- Issue date: 2004 Sep
- Experience with the use of palivizumab together with infection control measures to prevent respiratory syncytial virus outbreaks in neonatal intensive care units.
- Authors: Kurz H, Herbich K, Janata O, Sterniste W, Bauer K
- Issue date: 2008 Nov
- The use of palivizumab monoclonal antibody to control an outbreak of respiratory syncytial virus infection in a special care baby unit.
- Authors: Cox RA, Rao P, Brandon-Cox C
- Issue date: 2001 Jul
- Use of palivizumab with other infection control measures to control respiratory syncytial virus outbreaks in neonatal care units.
- Authors: Hammoud MS, Al-Taiar A, Raina A, Elsori D, Al-Qabandi S, Al-Essa M
- Issue date: 2016 Oct
- Palivizumab prophylaxis during nosocomial outbreaks of respiratory syncytial virus in a neonatal intensive care unit: predicting effectiveness with an artificial neural network model.
- Authors: Saadah LM, Chedid FD, Sohail MR, Nazzal YM, Al Kaabi MR, Rahmani AY
- Issue date: 2014 Mar